Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/13/1124   
Active ingredient: 2-hydroxypropyl--cyclodextrin
Indication: Treatment of Niemann-Pick disease, type C
Sponsor: International Niemann-Pick Disease Alliance (INPDA)
Suite 2, Vermont House, Concord, Washington, Tyne & Wear, NE37 2SQ, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/04/2013 Centralised Orphan - Designation EMA/OD/191/12 (2013)2561 of 26/04/2013